Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.
Validated QuEChERS-HPLC-UV Method for Quantification of Cannabidiol in Pharmaceutical Nanoformulations.
Chempluschem · 2026 Oct · PubMed
Cannabidiol in Adults With Lennox-Gastaut Syndrome: Real-World Experience.
Eur J Neurol · 2026 Oct · PubMed
Rivastigmine-centered molecular hybridization strategies for multi-targeted intervention in Alzheimer's disease: Advances (2020-2026).
Bioorg Med Chem · 2026 Sep 25 · PubMed
Cannabidiol in small animal practice: current evidence, clinical applications and practical recommendations for dogs and cats.
J Small Anim Pract · 2026 Sep 27 · PubMed
Subchronic Exposure to Cannabis-Based Nanoemulsions Induces Histopathological and Molecular Alterations in the Rat Submandibular Gland.
J Appl Toxicol · 2026 Sep 28 · PubMed
Cannabidiol (CBD) differentially shapes systemic cytokines and transcriptomic profiles in the liver and spleen: insights from a male mouse model.
Mol Genet Genomics · 2026 Sep 28 · PubMed
Plant-derived Bioactive Compounds in Schizophrenia: Pharmacological Mechanisms and Emerging Drug Targets.
Curr Drug Targets · 2026 Sep 29 · PubMed
Emerging therapies for pericarditis: from anti-IL-1 agents to novel therapeutic options.
Expert Opin Emerg Drugs · 2026 Sep 29 · PubMed